(Q45236167)

11 December 2017

title

Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study (English)

1 reference

11 December 2017

1 reference

1 reference

5

Guy Boeckxstaens

1 reference

11 December 2017

8

Jan Dzieniszewski

1 reference

11 December 2017

3

Nicholas J Talley

1 reference

11 December 2017

1

Michael A Kamm

1 reference

11 December 2017

author name string

Stefan Müller-Lissner

2

1 reference

11 December 2017

Jan Tack

4

1 reference

11 December 2017

Oleg N Minushkin

6

1 reference

11 December 2017

Andrey Kalinin

7

1 reference

11 December 2017

Peter Haeck

9

1 reference

11 December 2017

Fiona Fordham

10

1 reference

11 December 2017

Sophie Hugot-Cournez

11

1 reference

11 December 2017

Brigitte Nault

12

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

The American Journal of Gastroenterology

11 December 2017

published in

1 reference

11 December 2017

volume

100

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

362-372

1 reference

Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

Lack of objective evidence of efficacy of laxatives in chronic constipation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

The treatment of chronic constipation in adults. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

Alterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

Measurement of health status. Ascertaining the minimal clinically important difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

Generic and condition-specific outcome measures for people with osteoarthritis of the knee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40749.X

10.1111/J.1572-0241.2005.40749.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference